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Acute physical exercise and repeated exercise stimuli affect whole-body metabolic and immunologic homeostasis. The aim of this
study was to determine plasma protein profiles of trained (EET, 𝑛 = 19) and untrained (SED, 𝑛 = 17) individuals at rest and in
response to an acute bout of endurance exercise. Participants completed a bicycle exercise test at an intensity corresponding to
80% of their VO
2max. Plasma samples were taken before, directly after, and three hours after exercise and analyzed using multiplex
immunoassays. Seventy-eight plasma variables were included in the final analysis. Twenty-nine variables displayed significant acute
exercise effects in both groups. Seven proteins differed between groups, without being affected by acute exercise. Among these
A2Macro and IL-5 were higher in EET individuals while leptin showed elevated levels in SED individuals. Fifteen variables revealed
group and time differences with elevated levels for IL-3, IL-7, IL-10, and TNFR2 in EET individuals. An interaction effect could be
observed for nine variables including IL-6, MMP-2, MMP-3, and muscle damage markers. The proteins that differ between groups
indicate a long-term exercise effect on plasma protein concentrations.These findings might be of importance in the development of
exercise-based strategies in the prevention and therapy of chronicmetabolic and inflammatory diseases and for trainingmonitoring.
1. Introduction
Elucidating the complex processes that determine the human
body’s ability to adapt to specific training stimuli is crucial
to improve athletic performance in elite sports. Moreover,
targeted exercise-based intervention programs provide enor-
mous potential to combat the global epidemic increase of
chronic metabolic and inflammatory disorders including
obesity, metabolic syndrome, and type II diabetes. The
systemic and physiological responses to exercise are com-
plex and not well understood and involve a wide range
of metabolic, immunological, and hormonal changes [1].
Hereby, the immediate systemic response to acute exercise
is known to be closely dependent on the type, duration, and
intensity of exercise. However, also the individuals’ training
status has a major impact on the systemic response to
acute exercise, indicating an adaptive response to long-term
changes in whole-body repetitive exercise stimuli [2].
There is extensive research dealing with the specific
response of different exercise regimes in relation of age, gen-
der, training status, and physical conditions including obesity
and diverse chronic inflammatory disorders [3–9]. Most of
these studies focus on exercise-induced responses of selected
plasma cytokines altered by acute exercise stimuli [10–14].
Besides their roles in mediating immunological responses,
specific cytokines have recently emerged to profoundly influ-
ence diverse nonimmunological processes, including met-
abolic functions (e.g., glucose and lipid metabolism), repair
and/or prevention of tissue damage, and skeletal muscle
remodeling [15–17].These diverse actions depend on complex
and still largely undeciphered crosstalk with various other
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Table 1:The anthropometric data and performance results of the entrance examination and endurance exercise of EET and SED individuals.
Shown are mean ± SD and in parentheses the 1. quartile, median, and the 3. quartile. ∗∗∗𝑝 < 0.001 indicates significant differences between
endurance-exercise-trained (EET) athletes and untrained/sedentary (SED) individuals.
EET (𝑛 = 19) SED (𝑛 = 17)
Anthropometric data
Age (years) 25 ± 2.9 (24, 26, 27) 24 ± 3.5 (21, 22, 28)
Weight (kg) 73.9 ± 8.3 (70, 73, 77) 77.9 ± 12.4 (69, 76, 84)
Height (kg) 180.4 ± 6.5 (174, 181, 186) 177.9 ± 5.5 (174, 176, 180)
BMI 22.5 ± 1.6 (21, 23, 24) 24.7 ± 4.1 (22, 24, 27)
Entrance examination
VO
2max [mL/min/kg]
∗∗∗ 65.6 ± 6.7 (61, 66, 71) 40.5 ± 6.1 (39, 41, 45)
Maximum performance [watts]∗∗∗ 339.5 ± 45.9 (307, 333, 387) 206.4 ± 32.4 (202, 217, 225)
Maximum performance [watts/kg]∗∗∗ 4.6 ± 0.6 (4.0, 4.5, 5.0) 2.7 ± 0.5 (2.5, 2.8, 3.1)
Maximum lactate [mmol/L] 12 ± 2.0 (11, 12, 13) 10.4 ± 3.2 (7, 10, 13)
Maximum HR [beats/min] 188.9 ± 10.0 (183, 191, 196) 188.7 ± 9.3 (182, 188, 197)
Performance at IAT [watts/kg]∗∗∗ 2.9 ± 0.5 (2.5, 2.7, 3.3) 1.4 ± 0.4 (1.2, 1.6, 1.7)
Lactate at IAT [mmol/L] 2.4 ± 0.4 (2.0, 2.4, 2.7) 2.5 ± 0.5 (2.1, 2.5, 2.7)
Exercise performance
Performance at 80%VO
2max [watts]
∗∗∗ 254.1 ± 45.4 (227, 240, 280) 156.4 ± 32.0 (150, 167, 175)
Average lactate [mmol/L] 6.7 ± 3.1 (4.1, 5.9, 8.9) 6.1 ± 2.9 (3.8, 4.9, 7.1)
HR at end [beats/min] 178.8 ± 12.4 (168, 178, 189) 177.4 ± 8.2 (170, 175, 184)
BMI = Body Mass Index; HR = heart rate; IAT = individual anaerobic threshold; VO2max = maximal oxygen consumption.
metabolic and humoral biomolecules that are also released in
response to physical activity. These signaling molecules can
act synergistically as well as in an independent manner to
meet the specific physiological andmetabolic demands of the
exercising body. The simultaneous detection of a wide range
of plasma biomolecules by recently developed multianalyte
profiling methods now offers the possibility of generating
a more comprehensive picture of the complex systemic
responses to exercise [18]. In the present study, an evaluation
of at least 90 plasma proteins in trained and untrained indi-
viduals at rest and in response to a standardized endurance
exercise protocol was conducted. This approach offers the
unique opportunity to obtain more comprehensive insights
into the systemic response to acute exercise under the pre-
condition of different training statuses. Our analyzed panel
included various cytokines and their soluble receptors, as
well as acute-phase proteins, hormones, metabolic marker
proteins, and muscle damage markers. We hypothesized
that regular endurance exercise should be reflected by spe-
cific baseline plasma signatures and that acute exercise-
provoked plasma variable profiles should display training
status dependent response patterns. The determination of
protein profiles under different preconditions will contribute
to a better understanding of the complex mechanisms of
systemic exercise-induced adaptation processes. These find-
ings can be of importance for training monitoring in elite
sports and in the development of exercise-based strategies
for the prevention and/or therapy of chronic metabolic and
inflammatory degenerative diseases. In a previous study, we
analyzed skeletal muscle specimen from a subset of these
individuals using an off-gel liquid chromatography tandem
mass spectrometry (LC-MS/MS) approach. Proteome profil-
ing revealed differences in variousmetabolic, especiallymito-
chondrial proteins between endurance-trained anduntrained
individuals under resting conditions and in response to acute
exercise [19]. In addition, a subgroup analysis of participants
and variables was performed in connection with extracellular
DNA traps and cell-free DNA evaluation in plasma [20].
2. Methods
2.1. Participants and Group Characterization. Healthy male
endurance-exercise-trained (EET) athletes as well as un-
trained/sedentary (SED) individuals were recruited based on
training history and aerobic capacity. The inclusion criteria
for the EET group (𝑛 = 19) were regular endurance exer-
cise training of minimum 5 hours per week for at least 5
years before participation and an individual maximal oxygen
uptake (VO
2max) > 57mL/min/kg body weight (BW). The
inclusion criteria for the SED group (𝑛 = 17) were less
than 2 hours of unspecific sports per week and a VO
2max <
47mL/min/kg BW.The anthropometric data for both groups
are shown in Table 1. All experimental procedures were
approved by the local Ethics Committee of Justus-Liebig
UniversityGiessen, theUniversityHospital of Tuebingen, and
the University of Ulm. Each participant underwent a medical
screening and had to sign a written consent before the exper-
imental procedure.
2.2. Performance Diagnostic. Initially, maximum oxygen
uptake was determined by cardiopulmonary exercise testing
(MetaLyzer; CORTEX Biophysics, Leipzig, Germany) with
an incremental protocol on a bicycle ergometer (Excalibur
Sport; Lode, Groningen, Netherlands) to determine the
VO
2max including capillary blood lactate diagnostics (Biosen;
EKFDiagnostics,Magdeburg, Germany) to evaluate the indi-
vidual performance. Results of the performance diagnostics
are shown in Table 1.
2.3. Exercise Protocol and Sample Collection. Within one
to four weeks after the performance diagnostic, the main
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Figure 1: Experimental setup of the study enrollment.
exercise protocol was performed. Participants had to abstain
from physical activity for 3 days before intervention. After
an overnight fast (from 21.00 pm to 08.00 am), participants
received standardized breakfast and lunch on the day of acute
exercise. On the day before, blood samples were taken at rest
(called the “pre”measurements) under the same standardized
conditions.
The exercise setup comprised an acute endurance exercise
protocol on a bicycle ergometer for 50min at an intensity
(watts) corresponding to 80% of their individual VO
2max. A
10min warm-up at 60% of their individual VO
2max preceded
the endurance trial. Study participants were instructed to
drink a defined amount of water corresponding to their body
weight at two points in time during the cycling exercise proto-
col. At ten minutes and at three hours after the acute exercise
protocol, further blood samples were collected (called “post”
and “3 h,” resp.). A schematic drawing of the study can be
found in Figure 1.
2.4. Analysis of Whole Blood and Plasma Samples. EDTA
blood samples were collected for whole blood cell count and
preparation of plasma samples. Complete blood count was
accomplished by Synlab Lab Services (Synlab Medical Care
Center Kassel GmbH, Kassel, Germany). EDTA tubes for
plasma isolationwere kept on ice and centrifuged at 1600 g for
10min within 30min after collection (Universal 320R, Het-
tich centrifuges, Tuttlingen, Germany). Plasma supernatant
was collected, immediately frozen in liquid nitrogen, and
stored at −80∘C.
Quantification of 90 analytes in EDTA plasma samples
was performed at Myriad Rules-Based Medicine (Myriad
RBM, Austin, USA) using HumanMAP v. 1.6 of their
Luminex-based multiplex immunoassays as described by the
vendor. Only variables that could be detected in at least 80%
of the plasma samples were taken into account for further
statistical analysis, using a procedure for multiplex measure-
ments [21, 22]. This procedure resulted in the inclusion of 78
of the 90 available variables of HumanMAP v. 1.6. Samples
of the included variables that had no detectable value were
set at half of the lowest measured value for the corresponding
variable. To exclude biased measures due to plasma volume
shift, changes in plasma concentrations were calculated from
haemoglobin and haematocrit values, and concentrations
of postexercise variables were corrected as described by
Kraemer and Brown [23] and accomplished previously [20].
In addition, granulocyte-colony stimulating factor (G-
CSF) was chosen for separate analysis on the basis of recent
findings in its role in exercise delayed neutrophil apoptosis
and progenitor cell mobilization [14, 24]. G-CSF concentra-
tion in plasma samples was measured using a high sensitive
enzyme-linked immunosorbent assay (hsELISA) kit (R&D
Systems, Minneapolis, USA) according to the manufacturers’
instructions. The concentration of G-CSF was calculated
using MikroWin 2000 v. 4.34 (Mikrotek Labor Systems,
Overath, Germany). Mean ± standard deviation (SD) and
median with the 1. and 3. quartile for all included variables
can be found in Supplemental Table S1 in Supplementary
Material available online at http://dx.doi.org/10.1155/2016/
4851935.
2.5. Statistical and Bioinformational Analysis. Physiological
data were statistically analyzed using Wilcoxon’s rank sum
test for independent samples for differences between groups
and presented as mean ± SD and median with the 1. and
3. quartile. Plasma and whole blood data were statistically
analyzed using a nonparametric two-factorial analysis of
variance (ANOVA) for longitudinal data to assess the main
effects of time and group and their interaction effects [25].
The chosen nonparametric method allows us to analyze the
data without the need of normality or data transformations
[25]. The analysis is based on the so-called relative treat-
ment effects (RTEs) and data are presented as RTE with
the corresponding 95% confidence intervals (CI). Briefly
described, a RTE has a value between 0 and 1 and indicates
the probability that a measurement in one group at a given
time point is larger than a value of this variable in any other
combination of group and time. Keeping this in mind, a RTE
> 0.5 means that the EET group tends to have larger values
than the SED group, whereas a RTE < 0.5 must be interpreted
as tendency towards lower values in EET group. For more
details see [25–27]. When a significant main effect was
observed, appropriate post hoc pairwise comparison for
different time points (repeated nonparametric one-factorial
ANOVA for longitudinal data with time as factor) or between
groups (Wilcoxon’s rank sum test) was performed. Corre-
lation analysis in the EET group for plasma variables that
differ significantly at baseline between groups with their
correspondingVO
2max was performed using Spearman’s rank
correlation. For all analysis a 𝑝 value < 0.05 was consid-
ered to be significant. Whenever necessary to account for
multiple testing, Holm’s correction method for 𝑝 values
was performed [28]. Hierarchical cluster analysis of the
RTEs was performed using Ward’s method. In addition,
the scores of the area under the curve with respect to the
increase (AUCI) were calculated for all plasma variables and
compared by Student’s 𝑡-test or Wilcoxon’s rank sum test
when appropriate as described previously [29]. AUCI scores
for significant different variables are shown in Supplemental
Table S2. The statistics software R, version 3.0.2 [30], and
the packages nparLD [26] and nparcomp [31], GraphPad
Prism 5.0 (GraphPad Software, La Jolla, USA), JMPPro 10.0.2
(SAS Institute, Cary, USA), and IBM SPSS v. 21 (IBM Corp.,
Armonk, USA) were used for statistical analysis.
3. Results
3.1. Acute Endurance Exercise Trial. The acute endurance
exercise at 80%VO
2max in watts led to a significantly higher
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Table 2: Leukocytes, neutrophils, lymphocytes, and monocytes counts are shown in cells/𝜇L. Displayed is the median with the 1. and 3.
quartile in parentheses. ∗∗𝑝 < 0.01 and ∗∗∗𝑝 < 0.001 indicate significant differences from baseline.
Variable Median (1. quartile; 3. quartile)
Pre Post 3 h
Leukocytes 5080 (4030; 5755) 6209 (5518; 7645)∗∗∗ 8998 (7496; 10565)∗∗∗
Neutrophils 2614 (2164; 3343) 3556 (2954; 4606)∗∗∗ 6427 (5448; 8472)∗∗∗
Lymphocytes 1672 (1397; 1850) 2097 (1810; 2456)∗∗∗ 1561 (1350; 1773)
Monocytes 378 (299; 439) 478 (375; 602)∗∗ 501 (397; 610)∗∗∗
workload in the EET group (𝑝 < 0.001). There were no
differences in lactate levels and heart rate (HR) between the
two groups during the one-hour-lasting exercise (Table 1).
Lactate values started to increase significantly after half of
the main exercise protocol was completed and remained
elevated until the end of the exercise trial, with no significant
differences between groups (𝑝 < 0.001).
3.2. Leukocyte Counts. Total leukocytes and neutrophil num-
bers significantly increased over time until 3 h after exercise.
Lymphocytes andmonocytes increased directly after exercise.
At three hours after exercise, lymphocytes had decreased to
baseline, whereas monocytes remained elevated (Table 2).
3.3. Plasma Variable Results
3.3.1. Response of Plasma Variables over Time Independent of
Group Affiliation. Twenty-nine of the 78 included variables
showed an effect in response to the acute exercise interven-
tion without differences between the EET and SED group
(Table 3(a)). Marked responses to exercise were observed
for the proinflammatory and chemoattractant interleukins
interleukin- (IL-) 1 beta (IL-1𝛽) and IL-16 directly after exer-
cise, whereas the anti-inflammatory IL-1𝛽 antagonist IL-
1 receptor antagonist (IL-1ra) showed a delayed increase
3 h after exercise. Matrix metalloproteinase-9 (MMP-9)
also increased over time, whereas its antagonist, the tis-
sue inhibitor of metalloproteinase-1 (TIMP-1), showed an
immediate response pattern and declined to baseline values
3 h after exercise. Other inflammation-associated analytes,
including the neutrophil-derived extracellular newly identi-
fied receptor for advanced glycation end-products binding
protein (EN-RAGE) as well as myeloperoxidase (MPO)
and the chemokine epithelial-derived neutrophil-activating
protein 78 (ENA-78) and the T-cell-specific protein RANTES
(RANTES), also increased markedly in response to exercise
and remained elevated at the 3 h time point. We could
further observe increased levels of growth factors such
as brain-derived neurotrophic factor (BDNF), granulocyte-
colony stimulating factor (G-CSF), stem cell factor (SCF),
and vascular endothelial growth factor (VEGF) directly after
exercise. G-CSF, SCF, and VEFG remained elevated 3 h after
exercise in contrast to BDNF. The same pattern applies
for plasma levels of adhesive glycoproteins thrombospondin
1 and von Willebrand factor (vWF) which also increased
immediately after exercise and remained elevated. The RTEs
of all 29 variables that display a significant time effect are
clustered in Figure 2(a).
3.3.2. Differences between Groups in Plasma Variables with-
out Acute Exercise Effects. Seven plasma variables differed
between groups at baseline but were not affected by the
exercise intervention (Table 3(b)). In the EET group, elevated
levels could be observed for the protease inhibitor protein
alpha-2-macroglobulin (A2Macro), Apolipoprotein (Apo)A-
I (Apo A-I), a major component of high-density lipoproteins
(HDL), and T-helper (Th) type 2 and hematopoietic cytokine
IL-5. In contrast, significant higher baseline values in the
SED group were evident for the very low density lipoprotein
component Apo C-III, the chemokine macrophage-derived
chemokine (MDC), the acute-phase protein serum amyloid
P-component (SAP), and the adipokine leptin.
3.3.3. Variables Which Revealed Group and Time Point Differ-
ences between Groups. Fifteen of the analyzed variables
showed significant main effects for both group and time
(Table 3(c)). We found group differences for the chemoat-
tractant proteins IL-8 and monocyte chemotactic protein-
1 (MCP-1) with higher levels in the EET group. Both che-
mokines increased directly after exercise in both groupswhile
MCP-1 already displayed elevated baseline levels in the EET
group. Likewise, baseline values of the anti-inflammatory IL-
10 differed between groups with increased levels in the EET
group. In response to exercise cytokine IL-10 increased in
both the EET and SED group but remained elevated only
in the EET group 3 h after exercise. Th2-type cytokines IL-
3 and IL-13 revealed no post hoc time effects but differed
markedly between groups with higher levels in the EET
group. Exercise-provoked increases in tumor necrosis factor-
alpha (TNF-𝛼) levels could only be observed in the EET
group directly in response to exercise. Concordantly, plasma
levels of tumor necrosis factor receptor 2 (TNFR2) were
significantly higher in the EET group—already at rest—
and an immediate increase in response to exercise could
only be observed in the EET group. The protease inhibitor
protein alpha-1-antitrypsin (AAT) was elevated in the EET
group compared to the SED group with exercise dependent
time effects in the SED group 3 h after exercise. We further
found myoglobin, an early and sensitive marker for muscle
membrane damage, to be elevated in the EET group at rest.
An exercise-provoked release over time could be observed
in both groups, with increasing levels at 3 h after exercise.
Similarly, the insulin antagonist anabolic growth hormone
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Table 3: Plasma variableswith significantmain effects of time (a), group (b), group and time (c), and interaction (groupby time) (d).Displayed
are the relative treatment effects (RTEs) and their corresponding 95% confidence intervals (CI) in parentheses. ∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and
∗∗∗
𝑝 < 0.001 indicate significant differences from baseline within each group based on the LD-F1 model; $𝑝 < 0.05, $$𝑝 < 0.01, and
$$$
𝑝 < 0.001 indicate significant differences for the main effect of group and for differences between groups for separate points of time
in (d); §𝑝 < 0.05 and §§𝑝 < 0.01 indicate significant interaction effects between group and time. EET: endurance-exercise-trained; SED:
untrained/sedentary.
(a)
Variable RTE (CI)
Pre Post 3 h
Adiponectin 0.47 (0.45; 0.5) 0.51 (0.5; 0.53) 0.51 (0.49; 0.53)
AFP 0.49 (0.46; 0.52) 0.56 (0.52; 0.6)∗ 0.45 (0.42; 0.48)
Apo H 0.46 (0.43; 0.50) 0.50 (0.47; 0.54) 0.53 (0.50; 0.56)∗∗∗
BDNF 0.44 (0.41; 0.47) 0.57 (0.55; 0.6)∗∗∗ 0.49 (0.46; 0.53)
EN-RAGE 0.25 (0.21; 0.30) 0.72 (0.67; 0.76)∗∗∗ 0.53 (0.49; 0.57)∗∗∗
Eotaxin 1 0.48 (0.44; 0.52) 0.56 (0.51; 0.61) 0.46 (0.40; 0.51)
EGF 0.46 (0.42; 0.49) 0.53 (0.5; 0.56)∗ 0.51 (0.48; 0.54)
ENA-78 0.44 (0.42; 0.47) 0.56 (0.53; 0.59)∗∗∗ 0.50 (0.47; 0.52)∗
G-CSF 0.40 (0.35; 0.46) 0.57 (0.54; 0.6)∗∗∗ 0.53 (0.49; 0.57)∗
ICAM-1 0.46 (0.42; 0.49) 0.53 (0.5; 0.57)∗ 0.51 (0.48; 0.54)
IL-1𝛽 0.39 (0.34; 0.46) 0.64 (0.57; 0.69)∗∗∗ 0.47 (0.41; 0.54)
IL-1ra 0.42 (0.37; 0.47) 0.52 (0.46; 0.59) 0.56 (0.50; 0.61)∗∗
IL-16 0.28 (0.25; 0.32) 0.67 (0.64; 0.70)∗∗∗ 0.55 (0.53; 0.57)∗∗∗
IL-18 0.46 (0.43; 0.49) 0.52 (0.49; 0.56) 0.51 (0.48; 0.55)∗
MIP-1𝛽 0.45 (0.41; 0.48) 0.50 (0.47; 0.53) 0.56 (0.52; 0.60)∗∗
MMP-9 0.27 (0.23; 0.31) 0.58 (0.53; 0.61)∗∗∗ 0.66 (0.61; 0.70)∗∗∗
MPO 0.34 (0.29; 0.39) 0.67 (0.61; 0.71)∗∗∗ 0.50 (0.45; 0.55)∗∗∗
PAI-1 0.46 (0.43; 0.49) 0.54 (0.51; 0.57)∗∗ 0.50 (0.46; 0.54)
PAPP-A 0.41 (0.35; 0.48) 0.60 (0.55; 0.66)∗∗∗ 0.49 (0.43; 0.54)
PAP 0.56 (0.53; 0.6) 0.58 (0.52; 0.63) 0.36 (0.31; 0.41)∗∗∗
SGOT 0.45 (0.40; 0.51) 0.46 (0.41; 0.52) 0.58 (0.53; 0.63)∗
SCF 0.45 (0.42; 0.48) 0.54 (0.51; 0.58)∗∗∗ 0.51 (0.48; 0.55)∗
RANTES 0.44 (0.41; 0.47) 0.57 (0.54; 0.59)∗∗∗ 0.49 (0.47; 0.52)∗
Thrombospondin 1 0.42 (0.39; 0.46) 0.59 (0.56; 0.62)∗∗∗ 0.49 (0.45; 0.52)∗
TSH 0.53 (0.48; 0.57) 0.58 (0.54; 0.63) 0.39 (0.35; 0.43)∗∗∗
TBG 0.46 (0.42; 0.50) 0.50 (0.47; 0.53) 0.54 (0.51; 0.58)∗
TIMP-1 0.43 (0.39; 0.48) 0.56 (0.51; 0.61)∗∗ 0.51 (0.46; 0.55)
VEGF 0.40 (0.37; 0.44) 0.53 (0.5; 0.57)∗∗∗ 0.57 (0.52; 0.61)∗∗∗
vWF 0.32 (0.26; 0.40) 0.60 (0.54; 0.66)∗∗∗ 0.58 (0.5; 0.64)∗∗∗
AFP = Alpha Fetoprotein; Apo H = Apolipoprotein H; BDNF = brain-derived neurotrophic factor; EN-RAGE: extracellular newly identified receptor
for advanced glycation end-products binding protein; EGF = Epidermal Growth Factor; ENA-78 = epithelial-derived neutrophil-activating protein 78;
G-CSF = granulocyte-colony stimulating factor; ICAM-1 = Intercellular Adhesion Molecule 1; IL-1𝛽 = interleukin-1 beta; IL-1ra = interleukin-1 receptor
antagonist; IL-16 = interleukin-16; IL-18 = interleukin-18; MIP-1𝛽 = macrophage inflammatory protein-1 beta; MMP-9 = matrix metalloproteinase-
9; MPO = myeloperoxidase; PAI-1 = Plasminogen Activator Inhibitor-1; PAPP-A = Pregnancy Associated Plasma Protein-A; PAP = Prostatic Acid
Phosphatase; RANTES = regulated upon activation normal T-cell expressed and secreted; SGOT = Serum Glutamic Oxaloacetic Transaminase; SCF
= stem cell factor; TSH =Thyroid Stimulating Hormone; TBG =Thyroxine Binding Globulin; TIMP-1 = tissue inhibitor of metalloproteinase-1; VEGF
= vascular endothelial growth factor; vWF = von Willebrand factor.
(b)
Variable RTE (CI)
A2Macro$$ 0.71 (0.60; 0.82)
Apo A-I$ 0.71 (0.60; 0.81)
Apo C-III$ 0.32 (0.21; 0.43)
IL-5$$ 0.77 (0.67; 0.87)
Leptin$$$ 0.09 (0.03; 0.14)
MDC$ 0.32 (0.22; 0.43)
SAP$$$ 0.22 (0.13; 0.31)
A2Macro = alpha-2-macroglobulin; APOA-I =ApolipoproteinA-I; ApoC-III =ApolipoproteinC-III; IL-5 = interleukin-5;MDC=macrophage-derived
chemokine; SAP = serum amyloid P-component.
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(c)
Variable Group RTE (CI)
Pre Post 3 h
AAT EET 0.55 (0.45; 0.65) 0.59 (0.48; 0.68) 0.66 (0.56; 0.74)
SED$$ 0.35 (0.27; 0.43) 0.35 (0.25; 0.47) 0.46 (0.38; 0.55)∗∗
CA-125 EET 0.48 (0.38; 0.59) 0.74 (0.63; 0.81)
∗∗∗ 0.52 (0.42; 0.61)
SED$ 0.38 (0.29; 0.48) 0.52 (0.42; 0.62)∗ 0.33 (0.25; 0.44)
CD40 EET 0.50 (0.4; 0.6) 0.68 (0.59; 0.76)
∗∗∗ 0.59 (0.49; 0.68)∗
SED$ 0.38 (0.29; 0.49) 0.44 (0.33; 0.55) 0.38 (0.28; 0.49)
GH EET 0.37 (0.31; 0.43) 0.85 (0.81; 0.87)
∗∗∗ 0.45 (0.4; 0.51)∗
SED$$ 0.22 (0.17; 0.29) 0.79 (0.74; 0.83)∗∗∗ 0.29 (0.22; 0.39)∗
Insulin EET 0.57 (0.48; 0.65) 0.30 (0.23; 0.39)
∗∗∗ 0.42 (0.31; 0.53)∗
SED$ 0.71 (0.59; 0.8) 0.46 (0.34; 0.58)∗∗ 0.57 (0.45; 0.68)
IL-3 EET 0.63 (0.54; 0.71) 0.62 (0.53; 0.7) 0.68 (0.59; 0.75)
SED$$$ 0.34 (0.26; 0.44) 0.31 (0.23; 0.4) 0.37 (0.29; 0.46)
IL-7 EET 0.59 (0.5; 0.67) 0.62 (0.53; 0.69) 0.66 (0.57; 0.74)
∗∗
SED$$ 0.36 (0.27; 0.47) 0.34 (0.26; 0.44) 0.39 (0.3; 0.48)
IL-8 EET 0.48 (0.39; 0.58) 0.73 (0.66; 0.79)
∗∗∗ 0.56 (0.46; 0.64)
SED$$ 0.33 (0.23; 0.45) 0.53 (0.41; 0.63)∗∗ 0.34 (0.26; 0.43)
IL-10 EET 0.37 (0.29; 0.46) 0.81 (0.74; 0.86)
∗∗∗ 0.56 (0.46; 0.65)∗∗
SED$$ 0.32 (0.24; 0.41) 0.56 (0.45; 0.65)∗∗ 0.36 (0.27; 0.46)
IL-13 EET 0.60 (0.51; 0.69) 0.55 (0.46; 0.64) 0.63 (0.53; 0.71)
SED$ 0.39 (0.3; 0.49) 0.38 (0.29; 0.48) 0.42 (0.32; 0.52)
MCP-1 EET 0.52 (0.42; 0.61) 0.77 (0.69; 0.83)
∗∗∗ 0.48 (0.4; 0.57)
SED$$ 0.28 (0.21; 0.37) 0.57 (0.44; 0.69)∗∗∗ 0.35 (0.25; 0.47)
Myoglobin EET 0.27 (0.21; 0.35) 0.58 (0.51; 0.64)
∗∗∗ 0.79 (0.74; 0.82)∗∗∗
SED$ 0.17 (0.14; 0.23) 0.41 (0.33; 0.50)∗∗∗ 0.76 (0.66; 0.83)∗∗∗
TNF-𝛼 EET 0.56 (0.47; 0.64) 0.64 (0.55; 0.71)
∗ 0.56 (0.47; 0.65)
SED$ 0.40 (0.3; 0.51) 0.44 (0.35; 0.53) 0.38 (0.29; 0.48)
TNFR2 EET 0.54 (0.45; 0.63) 0.74 (0.65; 0.8)
∗∗∗ 0.60 (0.52; 0.68)
SED$$$ 0.32 (0.24; 0.42) 0.38 (0.31; 0.47) 0.36 (0.28; 0.45)
VCAM-1 EET 0.53 (0.44; 0.63) 0.66 (0.57; 0.73)
∗ 0.60 (0.51; 0.69)
SED$ 0.33 (0.26; 0.42) 0.41 (0.32; 0.51)∗ 0.43 (0.34; 0.53)∗
AAT = alpha-1-antitrypsin; CA-125 = Cancer Antigen 125; CD40 = CD 40 antigen; GH = growth hormone; IL-3 = interleukin-3; IL-7 = interleukin-7;
IL-8 = interleukin-8; IL-10 = interleukin-10; IL-13 = interleukin-13; MCP-1 = monocyte chemotactic protein-1; TNF-𝛼 = tumor necrosis factor-alpha;
TNFR2 = tumor necrosis factor receptor 2; VCAM-1 = Vascular Cell Adhesion Molecule-1.
(d)
Variable Group RTE (CI)
Pre Post 3 h
B2M EET 0.48 (0.39; 0.57) 0.82 (0.75; 0.86)
∗∗∗ 0.60 (0.51; 0.69)∗
SED§/$$$ 0.26 (0.20; 0.34)$ 0.42 (0.34; 0.52)∗∗/$$$ 0.37 (0.29; 0.46)$
CA-19-9 EET 0.44 (0.34; 0.55) 0.52 (0.42; 0.62) 0.54 (0.45; 0.63)
SED§ 0.52 (0.41; 0.63) 0.52 (0.42; 0.62) 0.46 (0.36; 0.57)
CEA EET 0.47 (0.38; 0.57) 0.67 (0.58; 0.74)
∗∗∗ 0.48 (0.38; 0.58)
SED§ 0.42 (0.32; 0.53) 0.49 (0.39; 0.6) 0.45 (0.35; 0.56)
CK-MB EET 0.54 (0.45; 0.62) 0.69 (0.6; 0.75)
∗∗ 0.74 (0.69; 0.79)∗∗∗
SED§/$$$ 0.27 (0.21; 0.35)$$ 0.27 (0.20; 0.36)$$$ 0.44 (0.35; 0.53)∗∗/$$
FABP, heart EET 0.27 (0.2; 0.36) 0.67 (0.59; 0.73)
∗∗∗ 0.68 (0.6; 0.75)∗∗∗
SED§ 0.25 (0.19; 0.34) 0.44 (0.36; 0.54)∗∗∗/$ 0.67 (0.54; 0.77)∗∗∗
IL-6 EET 0.26 (0.2; 0.34) 0.81 (0.74; 0.85)
∗∗∗ 0.44 (0.34; 0.54)∗
SED§ 0.36 (0.26; 0.48) 0.64 (0.54; 0.73)∗∗∗ 0.50 (0.39; 0.61)
MMP-2 EET 0.52 (0.42; 0.61) 0.73 (0.65; 0.79)
∗∗∗ 0.61 (0.52; 0.69)∗
SED§§/$$ 0.35 (0.27; 0.43) 0.38 (0.30; 0.49)$$ 0.37 (0.29; 0.46)$
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(d) Continued.
Variable Group RTE (CI)Pre Post 3 h
MMP-3 EET 0.39 (0.31; 0.48) 0.81 (0.73; 0.86)
∗∗∗ 0.49 (0.40; 0.58)∗∗
SED§§ 0.33 (0.26; 0.41) 0.57 (0.47; 0.66)∗∗∗/$ 0.39 (0.3; 0.50)
PSA-f EET 0.52 (0.42; 0.61) 0.66 (0.55; 0.74)
∗∗ 0.50 (0.41; 0.59)∗∗
SED§ 0.43 (0.34; 0.53) 0.46 (0.37; 0.56) 0.40 (0.31; 0.51)
B2M = Beta 2 Microglobulin; CA-19-9 = Cancer Antigen 19-9; CEA = Carcinoembryonic Antigen; CK-MB = creatine kinase MB; FABP, heart = fatty
acid-binding protein, heart; IL-6 = interleukin-6; MMP-2 = matrix metalloproteinase-2; PSA-f = Prostate Specific Antigen.
(GH) differed between groups with significantly elevated
levels at rest in the EET group. GH immediately increase in
response to exercise and remained elevated 3 h after exercise
in both groups. In contrast, elevated levels of insulin could
be detected in the SED group compared to the EET group.
Insulin dropped immediately after exercise in both the EET
and SED group but remained decreased at 3 h after exercise
only in the EET group.
3.3.4. Variables That Differ Significantly in Time Courses
between the EET and SED Group. Nine of the analyzed vari-
ables exhibited a significant interaction effect between group
and time (Table 3(d)). Extracellular matrix proteins MMP-2
and MMP-3 revealed different time curves between EET and
SED group. An effect of exercise for MMP-2 could only be
observed in the EET group and MMP-3 remained elevated
only in the EET group at 3 h after exercise. Both MMP-2 and
MMP-3 were significantly enhanced in the EET group imme-
diately after exercise. The pleiotropic cytokine IL-6 increased
in response to exercise in both groups. The increase of IL-6
was more pronounced in the EET group immediately after
exercise but post hoc tests revealed no significant differences
between groups (𝑝 = 0.07). Interaction effects could also be
observed for the muscle damage markers creatine kinase MB
(CK-MB) and heart-type fatty acid-binding protein (FABP).
FABP increased directly after exercise with higher levels in
the EET group and remained elevated in both groups. CK-
MB was significantly higher at all three sampling points in
the EET group. However, a delayed increase also became
apparent in the SED group at 3 h after exercise.
The nonparametric analysis revealed no significant main
or interaction effects of time and groups for 19 variables.
These variables can be found in Supplemental Table S3.
RTEs for significant variables with group, group and time,
and interaction (group by time) effect for EET and SED
groups (Tables 3(b)–3(d)) are clustered in Figure 2(b). Plasma
variables that differ significantly between the EET and SED
group at baseline (pre) are displayed in Table 4. Correlation
analyses of baseline plasma variable values with VO
2max for
the EET group revealed a significant positive correlation for
Apo A-I (𝑟 = 0.66, 𝑝 = 0.03) and a negative correlation for
leptin (𝑟 = −0.68, 𝑝 = 0.02). All correlations can be found in
Supplemental Table S4.
4. Discussion
In the present study, we compared the plasma protein profiles
of endurance-exercise-trained (EET) and sedentary (SED)
Table 4: Plasma variables of Tables 3(c) and 3(d) with significant
differences between EET and SED individuals at baseline (pre).
Displayed are the relative treatment effects (RTEs) and their corre-
sponding 95% confidence intervals (CI). $𝑝 < 0.05 and $$𝑝 < 0.01
indicate significant differences between groups. EET: endurance-
exercise-trained; SED: untrained/sedentary.
Variable Group RTE (CI) pre
AAT EET 0.55 (0.45; 0.65)
SED 0.35 (0.27; 0.43)$
B2M EET 0.48 (0.39; 0.57)
SED 0.26 (0.2; 0.34)$
CK-MB EET 0.54 (0.45; 0.62)
SED 0.27 (0.21; 0.35)$$
GH EET 0.37 (0.31; 0.43)
SED 0.22 (0.17; 0.29)$
IL-3 EET 0.63 (0.54; 0.71)
SED 0.34 (0.26; 0.44)$$
IL-7 EET 0.59 (0.5; 0.67)
SED 0.36 (0.27; 0.47)$
MCP-1 EET 0.52 (0.42; 0.61)
SED 0.28 (0.21; 0.37)$
TNFR2 EET 0.54 (0.45; 0.63)
SED 0.32 (0.24; 0.42)$
VCAM-1 EET 0.53 (0.44; 0.63)
SED$ 0.33 (0.26; 0.42)$
AAT = alpha-1-antitrypsin; B2M = Beta 2 Microglobulin; GH = growth
hormone; IL-3 = interleukin-3; IL-7 = interleukin-7; IL-8 = interleukin-8; IL-
10 = interleukin-10; IL-13 = interleukin-13; MCP-1 = monocyte chemotactic
protein-1; TNF-𝛼 = tumor necrosis factor-alpha; TNFR2 = tumor necrosis
factor receptor 2; VCAM-1 = Vascular Cell Adhesion Molecule-1.
individuals at rest and the effects of an acute bout of intensive
endurance exercise on these circulating blood variables over
time in both groups.
4.1. Interplay of Immune System and Metabolic Regulation.
The systemic response to acute exercise relies on coordinated
crosstalk of body tissues to maintain metabolic and immune
homeostasis [32–34]. The immune system has to preserve
an adequate immune function towards exogenous pathogens
while maintaining self-tolerance to endogenous components
that are released during exercise from skeletal muscle and
other tissues. The acute endurance exercise increased circu-
lating levels of muscle cell damage and permeability markers
such as myoglobin, CK-MB, and FABP illustrating the need
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Figure 2: Hierarchical cluster analysis of significant variables with (a) main effect time point and (b) group, group and time, and interaction
effect at each time point between EET and SED individuals using Ward’s method. Differences are represented by the computed RTEs. Red
colour representing higher and green lower RTEs. EET: endurance-exercise-trained; SED: untrained/sedentary.
for an adequate self-tolerance in response to strenuous exer-
cise. Here, an increase in muscle damage markers could be
observed, especially in the EET group. Key cytokines IL-
3, IL-5, IL-7, and IL-13, which have the ability to skew T-
cell cytokine secretion to T-helper (Th) type 2 responses,
stimulate dendritic cell differentiation, and maintain T-cell
homeostasis [35, 36], showed significant group and time
effectswith higher levels in the EET group.These effects could
also be observed for immunosuppressivemediators IL-10 and
TNFR2 [37, 38]. These findings indicate that regular exercise
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provokes acute as well as long-term changes in Th2-type
(IL-5, IL-6, and IL-13) [39] and regulatory T-cell (Treg) (IL-
10) [37] cytokines with more pronounced effects in trained
athletes compared to sedentary participants.
Despite their role in inflammation, cytokines also func-
tion as mediators of energy metabolism signaling. Immune
function and metabolic regulation are tightly interconnected
when it comes to exercise-induced alterations. High IL-10
levels, for example, have been reported to promote insulin
sensitivity in humans and protect against insulin resistance
by diminishing TNF mediated intracellular signaling in
adipocytes [40]. Apo A-I, a major component of high-density
lipoprotein (HDL) particles, has been shown to have anti-
inflammatory effects on blood cells and adipocytes [41]
but is also postulated to improve cellular energy glucose
metabolism and increase glucose uptake by muscle cells [42].
Here, we could observe a positive correlation between Apo
A-I and the endurance capacity represented by VO
2max in
the EET group under resting conditions. Apo A-I was not
affected by acute exercise but showed a significant group
effect with higher levels in the EET group. In line with this,
the LC-MS/MS skeletal muscle analysis revealed elevated
levels of key enzymes of the oxidative energy metabolism in
the endurance-trained muscle and, therefore, the ability for
enhanced muscular glucose utilization [19]. During intense
endurance exercise, glucose is the major fuel for the exercis-
ing muscle mobilized from muscle and liver glycogen stores.
The observed decrease in blood insulin in response to exer-
cise, especially in the EET group, enables the mobilization of
glucose for energy expenditure. One key player in the acute
metabolic signaling is the pleiotropic cytokine IL-6 that is
locally secreted by the contracting skeletal muscle [43] and
found to be elevated in circulation in response to exercise
[17]. In the present study, the highest values of IL-6 for
both groups were measured immediately after exercise with
a more pronounced effect in the EET group. IL-6 has been
demonstrated to provide metabolic effects, like enhanced
glycogenolysis and fatty acid oxidation [15], which corre-
spond to the elevated abundance of mitochondrial enzymes
of the tricarboxylic acid and oxidative phosphorylation in
the endurance-trained skeletal muscle [19] and, therefore, the
possibility of utilizingmore substrate for energy expenditure.
IL-6 knockout mice showed an impaired carbohydrate and
lipid metabolism and, in addition, were insensitive towards
the metabolic effects of leptin despite elevated circulating
plasma leptin level [44]. Our study revealed significantly
lower plasma leptin levels in the EET group but no impact
of acute exercise. In addition, within the endurance-trained
individuals, leptin was negatively correlated with the VO
2max
at baseline. A reduction in blood leptin levels has recently
been implicated with both an improved endurance training
status and changes in body composition [45]. In addition
to its metabolic functions, leptin is considered to have
proinflammatory activity and stimulates Th1-type cytokines
[46] whereas the lower leptin levels in the EET group are
in line with the abovementioned shift towards Th2-type
cytokines in trained individuals. In contrast, the proinflam-
matory cytokine TNF-𝛼 and the chemokines IL-8 and MCP-
1 revealed group and time effects and were also increased
in the EET group after exercise. In the context of exercise,
one might speculate about metabolic functions of the rather
proinflammatory cytokines.MCP-1, for example, is suggested
to play a role in energy metabolism. MCP-1 knockout mice
showed increased insulin levels accompanied with impaired
glucose utilization [47].
4.2. Regulatory Interactions. Remarkably, the protease inhib-
itors AAT and A2Macro were found to be elevated in the
EET group whereas AAT also increased 3 h after exercise in
the SED group. AAT serves as an inhibitor of neutrophil-
derived elastase [48] andmight reflect a response to exercise-
provoked neutrophilia and increased elastase release to limit
its adverse effects [49]. Similarly, A2Macro, a well-known
inhibitor of proteinases, released byneutrophils in the inflam-
matory process, protects human tissue from collateral dam-
age caused by unregulated proteolytic activity [50].Moreover,
A2Macro binds to several cytokines, including TNF-𝛼, IL-
1𝛽, and IL-6, and modulates their biological activity. The
TNF-𝛼 complex may be removed by complex formation with
A2Macro from circulation and the biological activity of IL-
1𝛽 is inhibited by A2Macro [50]. In contrast, IL-6 activity has
been reported to remain partly active, and IL-6 is protected
from degradation and available for its target cells when
binding to A2Macro [50]. Supportive evidence comes from
the regulation of MMP-2 and MMP-3 in response to exercise
with significantly higher levels in the EET group. Despite
their role in the degradation of extracellular matrix pro-
teins and tissue remodeling, MMPs influence inflammatory
processes through their functional inactivation of cytokines
and chemokines like IL-1𝛽 [51, 52]. Therefore, protease
inhibitors andMMPsmight have the potential to diminish an
excessive proinflammatory reaction in response to exercise.
Accordingly, we suggest that the trained organism initiates
long-term adaptive processes to cope with exercise-induced
inflammatory and metabolic stress, thus allowing perfor-
mances at higher intensities without adverse effects. A deeper
understanding of exercise-induced alterations offers the pos-
sibility of prescribing customized exercise as medicine in
metabolic and inflammatory disorders like obesity, metabolic
syndrome, and type II diabetes.
5. Concluding Remarks
In the present study, we could demonstrate that acute strenu-
ous endurance exercise has differential effects on circulating
blood variables, depending on the athlete’s training status.
While a wide range of variables responded simultaneously to
exercise in sedentary and endurance-trained individuals, we
also identified plasma proteins that differ between groups in
response to acute exercise. In addition, the analysis revealed
plasma proteins that were not affected by acute exercise
but differed between groups at baseline, indicating long-
term homeostatic adaptations caused by regular endurance
exercise training. As a consequence of the systemic and
cellular adaptation to inflammatory and metabolic stress
evoked by regular exercise, trained athletes are capable of
performing at absolute higherworkloads. To achieve a similar
systemic burden in both groups, a standardized relative
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workload protocol was chosen (indicated by similar lactate
and HR values) that allows a physiological comparison
between groups. In consequence, the EET group performed
at a higher absoluteworkload and it should be considered that
postexercise plasma levels might also be affected by differ-
ences in exercise intensity of both groups.
We believe that our analysis provides meaningful new
insights into the effects of endurance exercise on metabolic
and inflammatory signaling and homeostasis. Systemic blood
variables that are capable of monitoring exercise adaptation
are of scientific value not only to improve athletic perfor-
mance in elite sports but also to develop exercise-based inter-
vention programs in the prevention and treatment of chronic
metabolic and inflammatory diseases.
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